New mouthwash could shield cancer patients from agonizing mouth sores
NCT ID NCT07325383
Summary
This study is testing whether a mouthwash containing N-acetylcysteine (NAC) can safely prevent painful mouth sores (mucositis) in adults undergoing stem cell transplants. About 106 patients will be randomly assigned to use either the NAC mouthwash or a placebo mouthwash, and neither they nor their doctors will know which one they get. The goal is to see if the NAC mouthwash reduces the number and severity of these sores, which are a common and debilitating side effect of transplant treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORAL MUCOSITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Institute of Oncology, Hematology, and Cell Therapy, Shariati Hospital
Tehran, Iran
Conditions
Explore the condition pages connected to this study.